Sedana Medical AB (SEDANA) - Cash Flow Conversion Efficiency

Latest as of December 2025: -0.006x

Based on the latest financial reports, Sedana Medical AB (SEDANA) has a cash flow conversion efficiency ratio of -0.006x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Skr-5.25 Million ≈ $-564.55K USD) by net assets (Skr900.78 Million ≈ $96.94 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Sedana Medical AB (SEDANA) defensive interval to measure how many days the company can operate on defensive assets alone.

Sedana Medical AB - Cash Flow Conversion Efficiency Trend (2016–2025)

This chart illustrates how Sedana Medical AB's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Sedana Medical AB Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Sedana Medical AB ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
OPTIMIZERx Corp
NASDAQ:OPRX
0.026x
Eurofins-Cerep SA
PA:ALECR
-0.042x
BCP Investment Corp.
NASDAQ:BCIC
0.112x
Apetit Oyj
HE:APETIT
0.118x
Hasen-Immobilien AG
STU:ABHA
0.010x
Sao Ta Foods JSC
VN:FMC
0.089x
Banco Santander Río S.A
BA:BRIO
-0.322x
IMI PLC
LSE:IMI
0.259x

Annual Cash Flow Conversion Efficiency for Sedana Medical AB (2016–2025)

The table below shows the annual cash flow conversion efficiency of Sedana Medical AB from 2016 to 2025. For the full company profile with market capitalisation and key ratios, see Sedana Medical AB market cap and net worth.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 Skr900.78 Million
≈ $96.94 Million
Skr-12.78 Million
≈ $-1.38 Million
-0.014x -15.51%
2024-12-31 Skr958.23 Million
≈ $103.12 Million
Skr-11.77 Million
≈ $-1.27 Million
-0.012x +68.70%
2023-12-31 Skr970.00 Million
≈ $104.39 Million
Skr-38.06 Million
≈ $-4.10 Million
-0.039x +65.02%
2022-12-31 Skr1.03 Billion
≈ $110.75 Million
Skr-115.43 Million
≈ $-12.42 Million
-0.112x -199.71%
2021-12-31 Skr1.10 Billion
≈ $118.53 Million
Skr-41.22 Million
≈ $-4.44 Million
-0.037x -162.86%
2020-12-31 Skr551.09 Million
≈ $59.31 Million
Skr-7.85 Million
≈ $-844.35K
-0.014x +6.83%
2019-12-31 Skr569.38 Million
≈ $61.27 Million
Skr-8.70 Million
≈ $-936.28K
-0.015x +42.41%
2018-12-31 Skr217.81 Million
≈ $23.44 Million
Skr-5.78 Million
≈ $-621.90K
-0.027x -723.16%
2017-12-31 Skr116.40 Million
≈ $12.53 Million
Skr495.60K
≈ $53.33K
0.004x -97.74%
2016-12-31 Skr1.26 Million
≈ $135.81K
Skr238.00K
≈ $25.61K
0.189x --

About Sedana Medical AB

ST:SEDANA Sweden Medical Devices
Market Cap
$87.23 Million
Skr810.59 Million SEK
Market Cap Rank
#19771 Global
#347 in Sweden
Share Price
Skr8.16
Change (1 day)
+0.49%
52-Week Range
Skr8.12 - Skr17.48
All Time High
Skr107.10
About

Sedana Medical AB (publ), a medtech and pharmaceutical company, develops, manufactures, and sells medical devices and pharmaceutical products in Sweden, Germany, and internationally. The company offers Sedaconda ACD-L and Sedaconda ACD-S, which are disposable medical devices that enable the administration of volatile anaesthetics; Sedaconda Syringe, a 50/60ml syringe; Sedaconda ACD starter kit; S… Read more